• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结阴性乳腺癌的生存及预后因素:长期随访研究结果

Survival and prognostic factors in node-negative breast cancer: results of long-term follow-up studies.

作者信息

Rosen P P, Groshen S, Kinne D W

机构信息

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

出版信息

J Natl Cancer Inst Monogr. 1992(11):159-62.

PMID:1627422
Abstract

Seven hundred sixty-seven patients treated at the Memorial Sloan-Kettering Cancer Center from 1964 through 1970 by mastectomy and axillary dissection have now been followed for a median of 18 years. This unusual database consists of a consecutive series of women cared for by physicians specialized in the treatment of breast cancer in one institution. The data suggest that patients with T1, N0, M0 tumors of 1 cm or less may be "cured" by mastectomy and axillary dissection, the estimated proportion of "cured" patients being 89%. The data also suggest that node-negative patients can be placed in categories of risk for recurrence on the basis of primary tumor size.

摘要

1964年至1970年间在纪念斯隆-凯特琳癌症中心接受乳房切除术和腋窝淋巴结清扫术治疗的767名患者,目前已随访了18年,中位数为18年。这个独特的数据库包含了在一个机构中由专门治疗乳腺癌的医生连续护理的一系列女性患者。数据表明,肿瘤大小为1厘米或更小的T1、N0、M0期患者,通过乳房切除术和腋窝淋巴结清扫术可能会“治愈”,“治愈”患者的估计比例为89%。数据还表明,可根据原发肿瘤大小将淋巴结阴性患者分为复发风险类别。

相似文献

1
Survival and prognostic factors in node-negative breast cancer: results of long-term follow-up studies.淋巴结阴性乳腺癌的生存及预后因素:长期随访研究结果
J Natl Cancer Inst Monogr. 1992(11):159-62.
2
Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.保乳手术联合放疗治疗早期乳腺癌的治疗结果及预后因素
Jpn J Clin Oncol. 2005 Mar;35(3):126-33. doi: 10.1093/jjco/hyi039.
3
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.乳腺微浸润癌治疗的选择与结果:腋窝淋巴结清扫对T1a和T1b病变治疗的影响
J Am Coll Surg. 1996 Dec;183(6):575-82.
4
Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.T1期乳腺癌患者肿瘤大小及腋窝淋巴结受累情况与预后的相关性
Cancer. 1998 Dec 15;83(12):2502-8.
5
[Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].[原发性肿瘤对乳腺癌乳房切除术后局部区域复发的预后有影响吗?]
Strahlenther Onkol. 1995 Jan;171(1):18-28.
6
Results of the National Cancer Institute early breast cancer trial.美国国立癌症研究所早期乳腺癌试验的结果。
J Natl Cancer Inst Monogr. 1992(11):27-32.
7
Recurrence in breast cancer. Analysis with frailty model.乳腺癌复发。基于脆弱模型的分析。
Saudi Med J. 2006 Aug;27(8):1187-93.
8
[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].[局部晚期非炎性乳腺癌的联合化疗及术前放疗治疗:120例患者的最新结果]
Cancer Radiother. 2004 Jun;8(3):155-67. doi: 10.1016/j.canrad.2004.01.001.
9
Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.印度女性保乳治疗的安全性与可行性:塔塔纪念医院二十年经验
J Surg Oncol. 2006 Aug 1;94(2):105-13. doi: 10.1002/jso.20497.
10
Management and outcomes of isolated axillary node recurrence in breast cancer.乳腺癌孤立性腋窝淋巴结复发的管理与结局
Arch Surg. 2006 Sep;141(9):867-72; discussion 872-4. doi: 10.1001/archsurg.141.9.867.